Value and Risk of Class I and III Antiarrhythmic Drugs.

Saved in:

Bibliographic Details
Title:	Value and Risk of Class I and III Antiarrhythmic Drugs.
Authors:	Burkart, Felix¹
Source:	Pacing & Clinical Electrophysiology. Mar1994, Vol. 17 Issue 3, p467-472. 6p.
Subjects:	Myocardial depressants, Arrhythmia treatment, Phenytoin, Mexiletine, Quinidine, Amiodarone, Cardiovascular agents
Abstract:	Discusses the value and risk of class one and three antiarrhythmic drugs. Phenytoin; Mexiletine; Aprindine; Encainide; Quinidine; Amiodarone; Prospective randomized clinical trial in patients at risk after myocardial infarction where physicians to avoid the pitfalls of previous antiarrhythmic trials.
Database:	Engineering Source

Description
Abstract:	Discusses the value and risk of class one and three antiarrhythmic drugs. Phenytoin; Mexiletine; Aprindine; Encainide; Quinidine; Amiodarone; Prospective randomized clinical trial in patients at risk after myocardial infarction where physicians to avoid the pitfalls of previous antiarrhythmic trials.
ISSN:	01478389
DOI:	10.1111/j.1540-8159.1994.tb01414.x